Friday 20 November 2026 Edition compiled at 07.38 NL EN FR
← Science
ScienceHealth

Bloodstream infections with resistant Klebsiella up 72 percent as Europe drifts off course on antibiotics

On European Antibiotic Awareness Day, the ECDC reports that only the fall in MRSA is on schedule, and even that progress is under pressure.

· latest source update wo · 3 sources · ECDC, News-Medical, EurekAlert · Compiled with AI
Illustration for this article

The European Centre for Disease Prevention and Control (ECDC) warns that the EU is largely missing its 2030 goals on antimicrobial resistance. Bloodstream infections with carbapenem-resistant Klebsiella pneumoniae, a bacterium that is especially dangerous in hospitals, were 72 percent higher in 2025 than in 2019, against a target of a 5 percent fall. The agency said so on Wednesday, European Antibiotic Awareness Day, as News-Medical and EurekAlert also reported.

Bloodstream infections with E. coli resistant to third-generation cephalosporins also rose, by 16.4 percent, against a targeted fall of 10 percent. Only MRSA is on track: those infections have fallen 19 percent since 2019, but rose again over the past two years. Human antibiotic consumption last year was 5 percent below 2019 levels, far from the 20 percent target. The share of first-line drugs from the WHO's so-called Access group rose from 61.1 to 62.5 percent, close to the 65 percent goal.

According to the ECDC, 90 percent of human antibiotic use takes place outside hospitals, at the GP or at home. This year's campaign is therefore aimed at parents, urging careful use of antibiotics in children. Between 2024 and 2026 the agency visited every member state to review its approach.

Spotted a mistake in this article? Let us know.